NCT01315301 Optimal Time to Initiate Antiretroviral Therapy in HIV & TB Coinfected Adults Being Treated for Tuberculosis Status UNKNOWN Phase NA
NCT01311505 Bioequivalence Study Comparing Rifampicin In A Fixed-Dose Combination (Rifampicin+Isoniazid, Myrin© 2) And The Reference Drug (Rifampicin, Rimactane®) Status COMPLETED Phase PHASE1
NCT01301144 Oral Urea Breath Testing for Diagnosis and Treatment Response in Pulmonary Tuberculosis Status COMPLETED Phase N/A
NCT01290081 Enhanced Tuberculosis Case Detection Among Substitution Treatment Patients Status COMPLETED Phase NA
NCT01288950 Vitamin D Supplementation Enhances Immune Response to Bacille-Calmette-Guerin (BCG) Vaccination in Infants Status COMPLETED Phase NA
NCT01262976 Safety and Immunogenicity Study of a Candidate Tuberculosis Vaccine in Human Immunodeficiency Virus (HIV)-Positive Adults Status COMPLETED Phase PHASE2
NCT01252537 Immunosuppression in HIV-infected Patients With Tuberculosis in Ethiopia Status COMPLETED Phase N/A
NCT01245036 Efficacy of Antituberculous Therapy in Management of Sarcoidosis Status COMPLETED Phase NA
NCT01242475 A Trial of the C-Tb Skin Test, When Given Intradermally to Healthy Volunteers Previously Vaccinated With BCG Status COMPLETED Phase PHASE2
NCT01241188 A Trial of the C-Tb Skin Test, When Given Intradermally to Adult Patients Recently Diagnosed With Active Tuberculosis (TB) Status COMPLETED Phase PHASE2
NCT01225640 PNU-100480 In Newly Diagnosed, Drug Sensitive Patients With Pulmonary TB; Early Bactericidal Activity; Whole Blood Assay Status COMPLETED Phase PHASE2
NCT01223976 Sensitivity and Specificity of QuantiFeron -TB Gold Test (QFT-G)in Patients With Psoriasis Status UNKNOWN Phase PHASE4
NCT01222338 Safety and Efficacy of Oral Immunomodulator in Tuberculosis (TB) and TB/HIV Patients Status COMPLETED Phase PHASE2
NCT01194180 A BCG Challenge Model Study to Assess Anti-mycobacterial Immunity Induced by BCG and a Candidate TB Vaccine, MVA85A Status COMPLETED Phase PHASE1
NCT01182259 The Incidence and Risk Factors of Side Effects During the Initial Phase of Rifater Therapy - a Prospective Study Status UNKNOWN Phase N/A
NCT01181856 Safety of Tuberculosis Vaccine, MVA85A, Administered by the Intramuscular Route and the Intradermal Route Status COMPLETED Phase PHASE1
NCT01167647 The Role of Routine Bacterial Culture Including Tuberculosis During Bronchoscopy: A Prospective Study Status COMPLETED Phase N/A